disease-prevention

Documents about disease-prevention

• A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon#910502ClinicalTrials.gov
• A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.#844724ClinicalTrials.gov
• Simplified Cardiovascular Management Study#908146ClinicalTrials.gov
• HHSD2002013F55785 — LEIDOS, INC. — Department of Health and Human Services ($29,840,195)#602154USAspending
• HHSD200201250135C — PFIZER INC. — Department of Health and Human Services ($976,909,702)#605189USAspending
• HHSD200201354508C — PFIZER INC. — Department of Health and Human Services ($925,342,194)#605251USAspending
• New Alzheimer’s Disease Diagnostics and Psychological Clinical Perspectives#397098OSF
• Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence Model#663227OpenAlex
• Mediterranean Diet and cardiovascular diseases: A 2024 update#173047HAL (France)
• Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)#174974ClinicalTrials.gov
• Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine#230442ClinicalTrials.gov
• Developmental origins of health and disease: a lifecourse approach to the prevention of non-communicable diseases#309902Southampton
• International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease#344695HAL (France)
• A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention#346819ClinicalTrials.gov
• Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults#353337ClinicalTrials.gov
• Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age#407774ClinicalTrials.gov
• Secondary prevention in 24, 431 patients with coronary heart disease: survey in primary care.#652659Enlighten Publications
• ABC of arterial and venous disease. Secondary prevention of transient ischaemic attack and stroke#652672Enlighten Publications
• Brain-to-Society Diagnostic for Prevention of Childhood Obesity and Chronic Disease#853043ClinicalTrials.gov
• Keep On Keep Up for Parkinson's#879846ClinicalTrials.gov
• Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders#890212ClinicalTrials.gov
• Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine#898177ClinicalTrials.gov
• Molecular Landscape of Complex Lifestyle Modification#908012ClinicalTrials.gov
• Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine#968149ClinicalTrials.gov
• Prevention of Dental Implant Diseases#968811ClinicalTrials.gov
• Minnesota Medicaid Incentives to Prevent Chronic Disease#1031888ClinicalTrials.gov
• National Gay and Bisexual Campaign by the Department of Community Services and Health: 3 x 30 second radio commercials#446520Open Research
• Stroke Prevention in Young Adults With Sickle Cell Anemia#847521ClinicalTrials.gov
• Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients#839066ClinicalTrials.gov
• 42 U.S.C. § 242s — Centers for Disease Control and Prevention Office of Women’s Health#595445US Code (LII)
• 43 U.S.C. § 1748d — Report on wildfire, insect infestation, and disease prevention on Federal land#595783US Code (LII)
• HHSD200201033943C — PFIZER INC. — Department of Health and Human Services ($1,216,905,022)#604980USAspending
• HHSD200201138203C — PFIZER INC. — Department of Health and Human Services ($1,040,375,444)#605116USAspending
• HHSD200201458152C — PFIZER INC — Department of Health and Human Services ($1,033,136,950)#605125USAspending
• HHSD200201793274C — PFIZER INC — Department of Health and Human Services ($1,028,966,218)#605129USAspending
• Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment#907691ClinicalTrials.gov
• Estimating the number of cardio-pulmonary events potentially averted by fine particulate matter air quality index activity guidelines#20019DOAJ
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials#125782Europe PMC
• Yellow fever outbreak in Angola incident management: situation report 15 May 2016#129059WHO IRIS
• A Web-Based Virtual Environment Behavioral Intervention as Cardiovascular Disease and Metabolic Disease Prevention Education in Persons With HIV: Evaluation of the LEARN Randomized Controlled Trial.#327260NCBI PubMed Central
• Birth order and disease risk across the human phenome#425912Springer Nature OA
• The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol#802555ClinicalTrials.gov
• High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China#846712ClinicalTrials.gov
• A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)#848271ClinicalTrials.gov
• REU-stop - Effect of Intensive Smoking Cessation Intervention on Smoking Cessation and Disease Activity in Patients With Rheumatoid Arthritis.#848304ClinicalTrials.gov
• Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus#877757ClinicalTrials.gov
• BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)#895567ClinicalTrials.gov
• The genesis and progression of the HIV/AIDS programme in KwaZulu-Natal : implications for learning and intensified action#1024236UZSpace
• Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis#847930ClinicalTrials.gov
• Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease#28470ClinicalTrials.gov